Medical Disorders
Resources
Basic InformationLookupsLatest News
Drop in Life Expectancy From COVID Much Worse for Black, Hispanic AmericansInnovative Kidney Donor 'Voucher' System Is Saving LivesMental Confusion an Early Warning Sign of Severe COVID-19COVID Caused Biggest Drop in U.S. Life Expectancy Since World War IIClot-Removing Procedure Can Sometimes Backfire for Stroke PatientsFDA to Add Warning to Pfizer, Moderna Vaccines About Rare Heart Issues in YoungAHA News: Silent Heart Attacks All Too Common, and Often OverlookedRash, Itch After COVID Vaccine Rare & Quickly ResolvesStudy Suggests COVID Vaccine Booster Shots Will Be NeededNo Need for Blood Thinners in Patients Sick at Home With COVID-19Heart Issues in Young COVID Vaccine Recipients Rare, Usually Mild and Quickly Resolve: ExpertsMore E-Scooter Rideshares, More InjuriesMore Than Half of People With Asthma Aren't Seeing a SpecialistAutopsy Study Shows How COVID Harms the BrainCOVID Deaths Drop to New Lows in U.S., While Vaccination Rates ClimbNot-So-Happy-Birthdays: Parties Helped Spread COVID, Study FindsAHA News: Should Rare Cases of Heart Inflammation Put Your COVID-19 Vaccine Plans on Hold?Obesity in Teens Raises Adult Diabetes Risk, Even After Weight LossNew Genetic Insights Into Cause of ALSScreen All Kids for Heart Problems, Pediatricians' Group SaysIn 11 States, Seniors' Low Vaccination Rates a 'Powder Keg' for New CasesSickle Cell Plagues Many Black Americans, But There's Hope for Better TreatmentsSurvivors' Plasma Helps Blood Cancer Patients Battle COVID-19Hospitals: One Reason COVID Is More Lethal for Black AmericansMany 'High Priority' Patients Aren't Getting Put on Kidney Transplant ListsU.S. to Spend $3.2 Billion to Help Develop Antiviral Pills for COVIDRed Cross Warns of Severe Blood ShortageHand Sanitizer Vapors Can Cause Nausea, DizzinessPfizer, Moderna Vaccines Do No Harm to Male Fertility: StudyLess Than 1% of People Who've Had Severe COVID Get Re-InfectedMold a Big Threat to People With COPDWhat Works Best to Ease Migraines?Pandemic Silver Lining: Fewer Dangerous Flare-Ups for COPD PatientsIs Zinc a Friend or Foe to Kidney Stones?Strict Rest Not Recommended After Sports-Linked Concussion, Experts SayEven Good Weather Didn't Lift Lockdown Blues: StudyU.S. ​COVID Death Toll Tops 600,000Third Dose of COVID Vaccine Boosts Protection in Transplant RecipientsCould a Type of Statin Raise Dementia Risks?Many U.S. Seniors May Need Better Knee Arthritis CareAfter COVID, Many Americans Are Struck by New Maladies: StudyCataracts: Common, and Easy to TreatThere Are Many Good Reasons for Kids to Get the COVID VaccineBabies Produce Strong Immune Response to Ward Off COVID-19: StudyNovavax's COVID Vaccine Shines in Latest TrialAHA News: U.S. Appears to Lose Ground in Controlling High Blood PressureWeight-Loss Surgeries Used Least in U.S. States That Need Them MostObesity Could Raise Odds for 'Long-Haul' COVID SymptomsSmokers, Obese People Need Major Heart Interventions Earlier in LifeOld Age No Bar to Successful Heart Transplant, Study Finds
Questions and AnswersVideosLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Antibiotics Won't Help Fight Lung-Scarring Disease IDF: Study

HealthDay News
by Robert Preidt
Updated: Jun 7th 2021

new article illustration

MONDAY, June 7, 2021 (HealthDay News) -- Antibiotics do not reduce the risk of hospitalization or death in patients with a lethal lung disease known as idiopathic pulmonary fibrosis, a new study finds.

"We were certainly disappointed in the results," said study co-author Dr. Imre Noth, chief of pulmonary and critical care medicine at UVA Health in Charlottesville, Va. "But we remain hopeful that in further downstream analyses, we may yet find groups of patients that were potentially benefiting. In the meantime, this study will make sure that no one takes antibiotics without need."

Idiopathic pulmonary fibrosis (IPF) causes scar tissue to build up in the lungs over time, preventing them from providing the body with sufficient oxygen. It usually affects people over 50, mostly men. Most live only two to five years after diagnosis.

The cause is unknown, but environmental and genetic factors, as well as lung infections, may play a role. Previous research has suggested that antibiotics might help.

To find out if that's true, researchers in 35 U.S. sites conducted a clinical trial with 513 patients, age 40 or older. Half received antibiotics (either co-trimoxazol or doxycycline); the rest received standard care.

After a median followup of 12.7 months (meaning half were followed longer, half for less time), there was no statistically significant difference between the two groups in breathing-related hospitalization or death, according to findings recently published in the Journal of the American Medical Association.

A previous study yielded similar findings, and authors of the new study say their results confirm that antibiotics should not be used as a general treatment for IPF.

However, they didn't rule out that antibiotics may benefit a small number of patients with known disruptions to their populations of microorganisms in their lungs.

"As the largest single study in IPF ever conducted, I think we are going to learn a lot as we look at things more closely," Noth said in a UVA news release. "Might our choice of antibiotics have been the right ones? Were there some patients that did better than others? Who should we be targeting for treatment? All things this study will help in the future."

More information

The U.S. National Heart, Lung, and Blood Institute has more on idiopathic pulmonary fibrosis.


SOURCE: UVA Health, news release, June 22, 2021




Facebook

Amazon Smile

 

Children and Adult services are available now with no wait time.  

Please contact HBH at 860-548-0101, option 2.

 


powered by centersite dot net